These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 36329336)

  • 1. The emerging relationship between vitamin K and neurodegenerative diseases: a review of current evidence.
    Emekli-Alturfan E; Alturfan AA
    Mol Biol Rep; 2023 Jan; 50(1):815-828. PubMed ID: 36329336
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurodegenerative Disorders of Alzheimer, Parkinsonism, Amyotrophic Lateral Sclerosis and Multiple Sclerosis: An Early Diagnostic Approach for Precision Treatment.
    Pathak N; Vimal SK; Tandon I; Agrawal L; Hongyi C; Bhattacharyya S
    Metab Brain Dis; 2022 Jan; 37(1):67-104. PubMed ID: 34719771
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New therapeutic strategy for Parkinson's and Alzheimer's disease.
    Esposito E; Cuzzocrea S
    Curr Med Chem; 2010; 17(25):2764-74. PubMed ID: 20586718
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of vitamin E on neurodegenerative diseases: an update.
    Icer MA; Arslan N; Gezmen-Karadag M
    Acta Neurobiol Exp (Wars); 2021; 81(1):21-33. PubMed ID: 33949169
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of Alcohol Drinking in Alzheimer's Disease, Parkinson's Disease, and Amyotrophic Lateral Sclerosis.
    Peng B; Yang Q; B Joshi R; Liu Y; Akbar M; Song BJ; Zhou S; Wang X
    Int J Mol Sci; 2020 Mar; 21(7):. PubMed ID: 32230811
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neurodegenerative Diseases and Flavonoids: Special Reference to Kaempferol.
    Rahul ; Siddique YH
    CNS Neurol Disord Drug Targets; 2021; 20(4):327-342. PubMed ID: 33511932
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Naringenin: A prospective therapeutic agent for Alzheimer's and Parkinson's disease.
    Goyal A; Verma A; Dubey N; Raghav J; Agrawal A
    J Food Biochem; 2022 Dec; 46(12):e14415. PubMed ID: 36106706
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Icariin: A Potential Neuroprotective Agent in Alzheimer's Disease and Parkinson's Disease.
    Khezri MR; Ghasemnejad-Berenji M
    Neurochem Res; 2022 Oct; 47(10):2954-2962. PubMed ID: 35802286
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuroprotection of Coenzyme Q10 in Neurodegenerative Diseases.
    Yang X; Zhang Y; Xu H; Luo X; Yu J; Liu J; Chang RC
    Curr Top Med Chem; 2016; 16(8):858-66. PubMed ID: 26311425
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Implications of Vitamin D in Multiple Sclerosis and Other Neurodegenerative Processes: Bibliometric Analysis and Systematic Review.
    Caballero-Villarraso J; Jiménez-Jiménez MJ; Escribano BM; Agüera E; Santamaría A; Túnez I
    CNS Neurol Disord Drug Targets; 2019; 18(6):478-490. PubMed ID: 31269889
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nanomedicine for Neurodegenerative Disorders: Focus on Alzheimer's and Parkinson's Diseases.
    Jagaran K; Singh M
    Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445784
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Are the protective benefits of vitamin D in neurodegenerative disease dependent on route of administration? A systematic review.
    Iacopetta K; Collins-Praino LE; Buisman-Pijlman FTA; Liu J; Hutchinson AD; Hutchinson MR
    Nutr Neurosci; 2020 Apr; 23(4):251-280. PubMed ID: 29985117
    [No Abstract]   [Full Text] [Related]  

  • 13. The Vitamin D Receptor as a Potential Target for the Treatment of Age-Related Neurodegenerative Diseases Such as Alzheimer's and Parkinson's Diseases: A Narrative Review.
    Lasoń W; Jantas D; Leśkiewicz M; Regulska M; Basta-Kaim A
    Cells; 2023 Feb; 12(4):. PubMed ID: 36831327
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurodegenerative diseases and therapeutic strategies using iron chelators.
    Ward RJ; Dexter DT; Crichton RR
    J Trace Elem Med Biol; 2015; 31():267-73. PubMed ID: 25716300
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prioritization of Drug Targets for Neurodegenerative Diseases by Integrating Genetic and Proteomic Data From Brain and Blood.
    Ge YJ; Ou YN; Deng YT; Wu BS; Yang L; Zhang YR; Chen SD; Huang YY; Dong Q; Tan L; Yu JT;
    Biol Psychiatry; 2023 May; 93(9):770-779. PubMed ID: 36759259
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic potentials of plant iridoids in Alzheimer's and Parkinson's diseases: A review.
    Dinda B; Dinda M; Kulsi G; Chakraborty A; Dinda S
    Eur J Med Chem; 2019 May; 169():185-199. PubMed ID: 30877973
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inosine in Neurodegenerative Diseases: From the Bench to the Bedside.
    Basile MS; Bramanti P; Mazzon E
    Molecules; 2022 Jul; 27(14):. PubMed ID: 35889517
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cerium oxide nanoparticles: a 'radical' approach to neurodegenerative disease treatment.
    Naz S; Beach J; Heckert B; Tummala T; Pashchenko O; Banerjee T; Santra S
    Nanomedicine (Lond); 2017 Mar; 12(5):545-553. PubMed ID: 28181459
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurodegenerative disorders and their treatment.
    Karran E; Palmer AM
    Drug News Perspect; 2007; 20(6):407-12. PubMed ID: 17925895
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vitamin E and neurodegenerative disorders associated with oxidative stress.
    Butterfield DA; Castegna A; Drake J; Scapagnini G; Calabrese V
    Nutr Neurosci; 2002 Sep; 5(4):229-39. PubMed ID: 12168685
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.